Clicky

Waking up early reduces the risk of suffering from depression, says new study

Waking up just one hour earlier could reduce a person’s risk of major depression by 23 per cent, suggests a sweeping new genetic study published in the journal JAMA Psychiatry. The study of 840,000 people, by researchers at the University of Colorado Boulder and the Broad Institute of MIT and Harvard, represents some of the […]

Waking up early reduces the risk of suffering from depression, says new study Read More »

Incorporating Esketamine into Practice for Treatment-Resistant Depression

Evolving Management Strategies for Treatment-Resistant Depression – Episode 11 May 27, 2021 Steven P. Levine, MD , Angelos Halaris, MD, PhD, APA, ACNP, CINP Angelos Halaris, MD, PhD, APA, ACNP, CINP , Lisa Harding, MD , Patricia Ares-Romero, MD, FASAM Patricia Ares-Romero, MD, FASAM Additional variables that require consideration if treating appropriate patients with treatment-resistant

Incorporating Esketamine into Practice for Treatment-Resistant Depression Read More »

Want to reduce your depression risk? Wake up an hour earlier | CU Boulder Today

Waking up just one hour earlier could reduce a person’s risk of major depression by 23%, suggests a sweeping new genetic study published May 26 in the journal JAMA Psychiatry. The study of 840,000 people, by researchers at University of Colorado Boulder and the Broad Institute of MIT and Harvard, represents some of the strongest

Want to reduce your depression risk? Wake up an hour earlier | CU Boulder Today Read More »

Digital therapeutic for postpartum depression granted FDA Breakthrough Device Designation – Med-Tech Innovation

Woebot Heath, a developer of relational technologies and tools to support mental health, has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation to the company’s digital therapeutic for the treatment of postpartum depression (PPD).  WB001 is an investigational digital therapeutic, delivered over eight weeks via a patient’s smartphone, that combines cognitive behavioural

Digital therapeutic for postpartum depression granted FDA Breakthrough Device Designation – Med-Tech Innovation Read More »